Free Trial

Aldeyra Therapeutics (ALDX) Earnings Date, Estimates & Call Transcripts

$3.79
-0.08 (-2.07%)
(As of 05/23/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(Mar. 7)
-$0.08 Beat By $0.13
Consensus EPS
(Mar. 7)
-$0.21
Skip Charts & View Estimated and Actual Earnings Data

ALDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aldeyra Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.15)$0.02($0.07)
Q2 20242($0.15)($0.10)($0.13)
Q3 20242($0.17)($0.15)($0.16)
Q4 20242($0.18)$1.42$0.62
FY 20248($0.65)$1.19$0.27

ALDX Earnings Date and Information

Aldeyra Therapeutics last released its earnings data on March 7th, 2024. The biotechnology company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.13. Aldeyra Therapeutics has generated ($0.51) earnings per share over the last year (($0.51) diluted earnings per share). Earnings for Aldeyra Therapeutics are expected to decrease in the coming year, from ($0.15) to ($0.41) per share. Aldeyra Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Aldeyra Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
3/7/2024Q4 2023($0.21)($0.08)+$0.13($0.08)--
11/3/2023Q3 2023-($0.14)($0.14)($0.14)--
8/3/2023Q2 2023($0.31)($0.15)+$0.16($0.15)--
5/4/2023Q1 2023($0.30)($0.27)+$0.03($0.27)--
3/9/2023Q4 2022($0.34)($0.22)+$0.12($0.22)--
11/10/2022Q3 2022($0.34)($0.25)+$0.09($0.25)--
8/5/2022Q2 2022($0.32)($0.30)+$0.02($0.30)--
5/5/2022Q1 2022($0.31)($0.29)+$0.02($0.29)--    
3/17/2022Q4 2021($0.31)($0.27)+$0.04($0.27)--    
10/27/2021Q3 2021($0.26)($0.27)($0.01)($0.27)--    
8/4/2021Q2 2021($0.24)($0.28)($0.04)($0.28)--    
5/5/2021Q1 2021($0.29)($0.25)+$0.04($0.25)--  
3/10/2021Q4($0.28)($0.30)($0.02)($0.35)--  
11/10/2020Q3 2020($0.27)($0.23)+$0.04($0.23)--  
8/6/2020Q2 2020($0.34)($0.25)+$0.09($0.25)--  
5/7/2020Q1 2020($0.48)($0.34)+$0.14($0.34)--  
3/12/2020Q4 2019($0.68)($0.47)+$0.21($0.47)--  
11/7/2019Q3($0.55)($0.69)($0.14)($0.69)--  
8/8/2019Q2 2019($0.51)($0.4939)+$0.0161($0.49)--  

Aldeyra Therapeutics Earnings - Frequently Asked Questions

When is Aldeyra Therapeutics's earnings date?

Aldeyra Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on ALDX's earnings history.

Did Aldeyra Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Aldeyra Therapeutics (NASDAQ:ALDX) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.13. Learn more on analysts' earnings estimate vs. ALDX's actual earnings.

How much profit does Aldeyra Therapeutics generate each year?

Aldeyra Therapeutics (NASDAQ:ALDX) has a recorded net income of -$37.54 million. ALDX has generated -$0.51 earnings per share over the last four quarters.

What is Aldeyra Therapeutics's EPS forecast for next year?

Aldeyra Therapeutics's earnings are expected to decrease from ($0.15) per share to ($0.41) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ALDX) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners